TrueBlue, Inc. — Institutional Ownership
Which tracked institutions hold TBI, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
24
Funds holding
$43571771
Total value held
Buying
15 added/new · 9 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $15550035 | 2230995 | +73150 | +3.39% |
| 2 | Ies Holdings, Inc. | $8962298 | 1285839 | +1285839 | NEW BUY |
| 3 | State Street Corp | $4582566 | 657470 | -16912 | -2.51% |
| 4 | Prudential Financial Inc | $2502558 | 359047 | -100300 | -21.84% |
| 5 | Bank Of America Corp /De/ | $2224908 | 319212 | -140318 | -30.54% |
| 6 | Goldman Sachs Group Inc | $1885482 | 270514 | +89844 | +49.73% |
| 7 | Jpmorgan Chase & Co | $1664247 | 239116 | -13464 | -5.33% |
| 8 | Northern Trust Corp | $1619054 | 232289 | -11178 | -4.59% |
| 9 | Morgan Stanley | $926638 | 132946 | +32705 | +32.63% |
| 10 | Ameriprise Financial Inc | $793918 | 113905 | +113905 | NEW BUY |
| 11 | Bank Of New York Mellon Corp | $642557 | 92189 | +3219 | +3.62% |
| 12 | Sei Investments Co | $501819 | 71997 | -44800 | -38.36% |
| 13 | Raymond James Financial Inc | $370992 | 53227 | -800 | -1.48% |
| 14 | Invesco Ltd. | $319951 | 45904 | +45904 | NEW BUY |
| 15 | Barclays Plc | $305864 | 43883 | -486 | -1.10% |
| 16 | Franklin Resources Inc | $228839 | 32832 | +2728 | +9.06% |
| 17 | Wells Fargo & Company/Mn | $168294 | 24146 | +13314 | +122.91% |
| 18 | Citigroup Inc | $94318 | 13532 | -28915 | -68.12% |
| 19 | Fifth Third Bancorp | $75695 | 10860 | +360 | +3.43% |
| 20 | Federated Hermes, Inc. | $68843 | 9877 | +9877 | NEW BUY |
| 21 | Ubs Group Ag | $55802 | 8006 | +8006 | NEW BUY |
| 22 | Pnc Financial Services Group, Inc. | $20638 | 2961 | +644 | +27.79% |
| 23 | Royal Bank Of Canada | $6000 | 867 | +667 | +333.50% |
| 24 | Amalgamated Financial Corp. | $455 | 15736 | +15736 | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.